Provided by Tiger Trade Technology Pte. Ltd.

WUXI XDC

73.050
-1.350-1.81%
Volume:4.96M
Turnover:359.93M
Market Cap:92.63B
PE:65.22
High:74.650
Open:74.150
Low:71.600
Close:74.400
52wk High:85.500
52wk Low:43.500
Shares:1.27B
HK Float Shares:1.27B
Volume Ratio:0.88
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.120
ROE:16.33%
ROA:9.32%
PB:7.02
PE(LYR):65.22
PS:11.42

Loading ...

Movement Alert|WuXi XDC Falls 3.08% in Regular Trading, Trading at HKD 55.05

Market Focus
·
Jun 26

Movement Alert|WuXi XDC Rises 3.01% in Regular Trading, CXO Sector Continues Rally Amid Buyback Wave and Analyst Endorsement

Market Focus
·
Jun 25

Wuxi Apptec Shares Rally Amid Sectorwide Gains After Tech Selloff, China Policy Support

Dow Jones
·
Jun 24

Hong Kong Stocks Climb 0.3%

Dow Jones
·
Jun 24

Movement Alert|WuXi XDC Rises 3.05% in Regular Trading, Analyst Recommendation and Subsidiary Order Continue to Boost Sentiment

Market Focus
·
Jun 24

HK Movers | Biotech Stocks Jump. InnoGen up over 17%; Alphamab, Hengrui Pharma, Laekna, Keymed Bio up Around 5%; Joinn, Remegen up About 4%

Tiger Newspress
·
Jun 23

Movement Alert|WuXi XDC Rises 3.24% in Regular Trading, BOCOM International Recommendation and Subsidiary Order Continue to Boost Sentiment

Market Focus
·
Jun 23

Movement Alert|WuXi XDC Rises 3.25% in Regular Trading, Boosted by BOCOM International Recommendation and Subsidiary Order from WuXi Biologics

Market Focus
·
Jun 22

Movement Alert|WuXi XDC Rises 3.18% in Regular Trading, Subsidiary Secures WuXi Biologics Order Amid Sector Rally

Market Focus
·
Jun 18

BIODLINK-B and WUXI XDC Forge Service Pact for Antibody Process Development and Production

Stock News
·
Jun 17

WuXi XDC: Subsidiary BioDlink Seals RMB19.00 Million Monoclonal-Antibody Manufacturing Deal with WuXi Biologics

Bulletin Express
·
Jun 17

WuXi XDC unit BioDlink wins RMB 19 million process development, manufacturing order from WuXi Biologics

Reuters
·
Jun 17

Movement Alert|WuXi XDC Falls 3.02% in Regular Trading, Buyback Fails to Halt Slide as Geopolitical Headwinds Pressure WuXi Group

Market Focus
·
Jun 16

Movement Alert|WuXi XDC Rises 3.01% in Regular Trading, Trading at HK$47.26

Market Focus
·
Jun 12

Movement Alert|WuXi XDC Falls 4.05% in Regular Trading, Buyback Efforts Fail to Halt Selling Pressure as Stock Trades Over 21% Below Repurchase Price

Market Focus
·
Jun 11

Movement Alert|WuXi XDC Falls 3.18% in Regular Trading, US DoD 1260H List and Persistent Selling Pressure Weigh on WuXi Group

Market Focus
·
Jun 10

Movement Alert|WuXi XDC Falls 3.59% in Regular Trading, Buyback Efforts Fail to Stem Selling Pressure Across WuXi Group

Market Focus
·
Jun 09

Movement Alert|WuXi XDC Falls 3.73% in Regular Trading, Intensive Buybacks Fail to Stem Selling Pressure as WuXi Group Under Broad Decline

Market Focus
·
Jun 08

HK Movers | Biotech Stocks Jump. Asymchem up Nearly 7%; SKB Bio up About 6%; Hengrui Pharma, Pharmaron, InnoGen up over 4%; Wuxi Apptec up 3%; Laekna, Joinn, Remegen up over 2%

Tiger Newspress
·
Jun 05

TOT Biopharm proposes Deloitte as new auditor as PwC retires

Reuters
·
Jun 04